Myeloma Bone Disease (Current Clinical Oncology) - Image 1

£140.26

Humana Myeloma Bone Disease (Current Clinical Oncology)

Name: Myeloma Bone Disease (Current Clinical Oncology)
Brand: Humana
Price: 140.26 GBP
Availability: InStock

Oncology

This is the most expensive it has ever been. Walk away.

£140 today · previous high £140 · all-time low £140

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 68 days · 68 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 68 days • 1 price levels

Days at Price

Price Analysis

Most common price: £140 (68 days, 100.0%)

Price range: £140 - £140

Price levels: 1 different prices over 68 days

Description

Multiple myeloma is the second most common hematologic malignancy and c- rently affects approximately 50,000 people in the United States. Each year about 20,000 people are diagnosed with myeloma. Although new treatments have been developed, which signi?cantly prolong the survival of patients, myeloma bone d- ease still remains a major cause of severe morbidity and increased mortality in patients with myeloma. Myeloma bone disease is characterized by "punched out" lytic lesions caused by increased osteoclastic bone destruction accompanied by suppressed or even absent osteoblast activity. Advances in our understanding of both the pathophysiology of myeloma bone disease and the development of novel agents that target speci?c pathways involved in both the increased osteoclast f- mation and the suppressed osteoblast activity in myeloma provide new hope for these patients. The treatment of myeloma bone disease was revolutionized by cl- ical trials that demonstrated the signi?cant bene?t of intravenous bisphosphonate therapy in patients with myeloma bone disease. With the identi?cation of many of the cytokines and chemokines involved in myeloma bone disease, novel th- apies such as denosumab that blocks RANKL activity, anti-DKK1, which targets the inhibition of osteoblast activity by blocking Wnt signaling inhibition, and the potential anabolic effects of agents such as bortezomib and activin have greatly improved our potential to block the progression or reverse myeloma bone disease.

Key Features

New

Mint Condition

Dispatch same day for order received before 12 noon

Guaranteed packaging

No quibbles returns

Product Specifications

Brand: Humana
Format: hardcover
ASIN: 1607615533
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 04 May 2010
Listed Since: 01 March 2010

Barcode

No barcode data available

Humana Myeloma Bone Disease (Current Clinical Oncology)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Prevention of Bone Metastases: 192 (Recent Results in Cancer Research, 192)

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Treatment of Multiple Myeloma and Related Disorders

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Bone Cancer: Progression and Therapeutic Approaches

Bone Tumors in Domestic Animals: Comparative Clinical Pathology

Dorfman and Czerniak's Bone Tumors

Bone Metastasis: Experimental and Clinical Therapeutics (Cancer Drug Discovery and Development)

Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)

Metastatic Bone Disease: An Integrated Approach to Patient Care

Therapie der akuten Leukämien

Osteoimmunology: Interactions of the Immune and Skeletal Systems

Advances in Pathobiology and Management of Paget's Disease of Bone

Orthopaedic Knowledge Update®: Musculoskeletal Tumors 5: Print + Ebook

Atlas of Bone Pathology (Atlas of Anatomic Pathology)

Bone Tumors: Evidence-based Approach in Diagnosis and Management

Bone Marrow: A Practical Manual (Vademecum)